Mirae Asset Global Investments Co., Ltd. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,871,650
-18.0%
37,269
+4.0%
0.00%
-20.0%
Q2 2023$2,281,249
+35.8%
35,852
-4.0%
0.01%
+25.0%
Q1 2023$1,679,387
+26.8%
37,328
+23.4%
0.00%
+33.3%
Q4 2022$1,324,726
-33.4%
30,238
+0.2%
0.00%
-40.0%
Q3 2022$1,988,000
+85.3%
30,175
+42.1%
0.01%
+66.7%
Q2 2022$1,073,000
-91.5%
21,240
-82.7%
0.00%
-90.6%
Q3 2021$12,650,000
+45.3%
123,042
+24.3%
0.03%
+33.3%
Q2 2021$8,706,000
+35.0%
98,984
+49.2%
0.02%
+9.1%
Q1 2021$6,451,000
+53.3%
66,349
+76.8%
0.02%
+37.5%
Q4 2020$4,208,000
+47.4%
37,523
+21.8%
0.02%
+14.3%
Q3 2020$2,855,000
+73.7%
30,801
+46.2%
0.01%
+40.0%
Q2 2020$1,644,000
+131.5%
21,070
+73.7%
0.01%
+66.7%
Q1 2020$710,000
-18.9%
12,130
+10.9%
0.01%
+20.0%
Q4 2019$876,000
+25.1%
10,937
+14.8%
0.01%0.0%
Q3 2019$700,000
+117.4%
9,528
+179.6%
0.01%
+150.0%
Q2 2019$322,0003,4080.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders